2Morrow

Overview
News
Mental Health Tech?
Product stageSegments
Go-to-Market
?
Digital Therapeutics
?

2Morrow provides digital health and well-being programs focused on behavior modification through smartphone applications and websites. The company's platform leverages behavioral science and Acceptance and Commitment Therapy (ACT) to help users make meaningful lifestyle changes. Their programs address various health concerns including tobacco cessation, stress management, chronic pain, and grief. The company's tobacco cessation program has demonstrated strong outcomes through clinical validation, including a Phase III randomized controlled trial involving 2,400 participants and over 10 peer-reviewed articles. The platform's approach centers on helping users align their actions with personal values and goals, offering brief, self-paced programs that can be completed in weeks. Users receive personalized content, daily lessons, messaging, customized tips, and access to live coaching support. As of 2024, the platform is utilized by major employers, states, and health plans across the US to support their populations' health initiatives. The tobacco cessation program specifically delivers significant cost benefits, with potential savings of up to USD 5,800 per employee annually in health costs and productivity gains.

Key customers and partnerships

2Morrow's solutions are employed by several state health departments, including the Washington State Department of Health, which uses their app for tobacco cessation support. In February 2024, the company entered into a partnership with Spring Health to enhance tobacco cessation support for Spring Health customers, integrating 2Morrow's behavioral-based cessation program into the Spring Health platform. The company also collaborates with the University of Colorado Cancer Center, which uses 2Morrow's app to help people quit smoking and vaping in Colorado.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
12020 113th Ave NE Suite 295 Kirkland WA USA
Founded year:
2012
Employees:
11-50
IPO status:
Private
Total funding:
USD 4.0 mn
Last Funding:
USD 1.9 mn (Grant; Jan 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.